Skip to content
    Telegraph Hill logo

    Telegraph Hill

    San Francisco, California, United StatesFounded 2001

    Telegraph Hill Partners is a venture capital and growth equity firm dedicated to helping life science, medical device, and healthcare companies achieve their growth objectives. Founded in 2001 and based in San Francisco, the firm invests in commercial-stage companies across life science tools, medical technology, healthcare IT, and healthcare services.

    Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $14.9M (across 30 rounds with reported amounts).

    Find people at Telegraph Hill on Goldilocks AI

    Portfolio

    30

    Fund Size

    $525M

    Top Stage

    Unknown

    Last 12 Mo

    1

    Team

    J. Matthew Mackowski

    J. Matthew Mackowski

    Chairman, Managing Director

    Alexander Herzick

    Alexander Herzick

    Partner

    Hart, J.D., CFA

    Hart, J.D., CFA

    Partner

    Robert Shepler

    Robert Shepler

    Partner Emeritus

    Jackson Savage

    Jackson Savage

    Associate

    Anthony Manupella

    Anthony Manupella

    Controller

    DM

    Dinesh Moorjani

    Managing Director

    MB

    Mark Bradt

    Managing Director

    MM

    Matthew Mackowski

    Chairman, Managing Director

    AH

    Alex Herzick

    Partner

    PG

    Paul Grossman

    Partner

    AA

    Andrew Alas

    Investment Banking Associate

    Looking for someone who isn't listed here?

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    34 investments
    CompanyRound
    Kytopen logoKytopenApr 2026Series B
    Streamforge logoStreamforgeJul 2025 · $1.2MSeed
    Bucketlist logoBucketlistJan 2025 · $1.2MUnknown
    FutureMoney logoFutureMoneyOct 2024 · $2.5MPre-Seed
    AArtemis, Inc.May 2024 · $1.5MPre-Seed
    AApartoolOct 2023Series A
    UnDosTres logoUnDosTresJul 2022 · $30MSeries B
    Voila logoVoilaJan 2022 · $6MSeries A
    Rarecyte logoRarecyteSep 2021 · $24MSeries B
    NNivagen PharmaceuticalsMay 2020 · $16MGrowth
    Stamped logoStampedFeb 2020 · $2MPre-Seed
    Nimble Therapeutics logoNimble TherapeuticsApr 2019 · $10MSeries A
    Akoya Biosciences logoAkoya BiosciencesJan 2019 · $50MUnknown
    AAkoyaJan 2019 · $50MUnknown
    Chewse logoChewseDec 2018 · $19MSeries B
    Captio logoCaptioSep 2016 · $1.1MUnknown
    Captio logoCaptioSep 2016 · $1.1MUnknown
    FFleetApr 2016 · $4MSeed
    PPneumRxJan 2011Series C
    Asuragen logoAsuragenDec 2007 · $18.5MSeries B
    Vessel logoVessel$7.5MSeed
    PPneumRx$27MSeries B
    QuoteMachine logoQuoteMachine$3.7MSeed
    PProvect.AI$7MUnknown
    Mosaic Biosciences logoMosaic Biosciences$11.4MUnknown
    Page 1 of 2

    Looking for the people behind these companies?

    Top Co-Investors

    Last updated: 18 November 2026